Updated:
Optum Ventures
Larry Renfro and Laura Veroneau's Optum Ventures manages $2B across 6 funds, investing in healthcare tech startups with UnitedHealth Group partnership.
Optum Ventures
Optum Ventures was created in 2017 as an independent venture capital firm in partnership with UnitedHealth Group. Larry Renfro, who previously ran UnitedHealth's Optum unit — growing it from a $27 billion health services platform to over $90 billion — led the firm alongside Laura Veroneau, a founding partner with experience at CVS Health and Transformation Capital. The leadership team also includes partners based in a London office, signaling an international purview alongside the firm's core US positioning. Deploying over $2 billion across six funds and more than 75 portfolio companies, Optum Ventures is stage-agnostic within early-to-growth venture. Its sector coverage clusters around value-based care delivery, enterprise software and enabling infrastructure, and healthcare fintech. Confirmed positions include Alma, a membership-based network for mental health providers; Ambience, which makes an AI medical scribe; Cedar, a patient financial engagement platform; and Somatus, a kidney-care integrated delivery platform. International investments include Doccla, a London-based virtual ward operator, and Florence, a UK healthcare staffing marketplace. The firm's dual anchoring in Boston and London corresponds with its concentrated North American deal flow and growing European activity. Optum Ventures operates with a team anchored by two managing partners and supported by investment staff across Boston and London. A Portfolio Management team and CFO's office indicate institutional-grade operations, and the London office, where partner Vijay Barathan leads global deal activity, highlights the firm's expanding geographic reach. The current investing posture traces to a period of portfolio build-out, including the addition of over 65 portfolio companies and the deployment of over $2 billion in AUM — figures the firm cites consistently. Optum Ventures is structurally distinguishable from most healthcare VC firms by its founding partnership with UnitedHealth Group, the largest US health insurer. While legally independent, the firm's access to claims data, care delivery networks, and operating executives at UnitedHealth function as a proprietary due-diligence and commercialization channel. This arrangement allows portfolio companies to test and scale within UnitedHealth's ecosystem, creating a potential exit path or distribution advantage that traditional venture platforms cannot replicate.
General information
Firm type
Venture Capital
Year founded
2017
AUM
over $2 billion in assets under management across 6 funds (per firm website, 2025)
Location
Region
North America
Country
United States
City
Boston
Corporate office
Boston, MA, United States
Additional offices
London, United Kingdom
Principals
Larry Renfro
Managing Partner
Laura Veroneau
Managing Partner
Sector focus
Frequently asked questions
Who runs investment decisions at Optum Ventures?
Larry Renfro and Laura Veroneau share the Managing Partner role. Renfro brings UnitedHealth Group operating experience — he ran Optum from $27 billion to over $90 billion before becoming Vice Chairman. Veroneau, a founding team member, previously worked at CVS Health and Transformation Capital. Both names appear across firm communications, suggesting a co-leadership model.
How is Optum Ventures related to UnitedHealth Group?
Optum Ventures was founded in 2017 as an independent venture capital firm in partnership with UnitedHealth Group. The firm operates with its own investment committee and team, but its founding mandate and ongoing connectivity to UnitedHealth's data, provider networks, and commercial relationships differentiate its sourcing and portfolio support from standalone healthcare VCs.
Does Optum Ventures participate in fund commitments or only direct deals?
The firm's disclosed activities focus on direct venture capital investments into healthcare technology startups from seed to growth equity. There is no public indication of fund-of-funds commitments or participation in third-party venture fund LP positions, as its six funds are deployed into more than 75 direct portfolio companies.
What investment stages does Optum Ventures typically target?
Optum Ventures describes itself as stage-agnostic, with confirmed activity spanning seed, early-stage, and growth equity. Its portfolio includes pre-revenue startups like Amigo AI and later-stage companies such as Somatus, which operates at scale in value-based kidney care. The firm does not publicly commit to a minimum or maximum initial check size.
Which healthcare sectors does Optum Ventures focus on?
The firm's website lists value-based care delivery, enterprise software and enabling infrastructure, and healthcare fintech as its three thematic pillars. Its confirmed sector focuses include Digital Health, Healthcare Services, Data Analytics, FinTech, InsurTech, Workflow Automation, and AI/ML. It also maintains active investments in virtual care, behavioral health, and life sciences data management.
Does Optum Ventures maintain a presence outside the United States?
Yes. Optum Ventures operates a London office from which Partner Vijay Barathan leads investments in Europe and other global markets. Confirmed international portfolio companies include Doccla, a London-based virtual ward operator, and Florence, a UK healthcare staffing marketplace. The firm's global team suggests active sourcing outside North America.
How does Optum Ventures source proprietary deal flow?
The firm's structural link to UnitedHealth Group provides access to claims data, payer networks, and strategic priorities that can surface investment opportunities earlier than generalist venture firms. It also benefits from the commercial validation that comes when a startup deploys inside UnitedHealth's operations, which can function as a proprietary signal for follow-on investing.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on venture capital firms?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: